公开(公告)号：US10702590B2

公开(公告)日：2020-07-07

申请号：US15478505

申请日：2017-04-04

Applicant: Script Essentials, LLC

Inventor： Suzy Cohen

IPC: A61K38/48 ,  A61K33/04 ,  A61K38/06 ,  A61K38/46 ,  A61K38/44 ,  A61K31/593 ,  A61K45/06

Abstract: The present disclosure relates to a compound and method of using such compound, preferably in the form of a dietary supplement that, when administered, is capable of treating thyroid disease and various thyroid-related disorders, such as Hashimoto's thyroiditis. The unique combination of the composition is preferably administered orally via acid resistant or enteric-coated capsule, soft gel or tablet. The composition is preferably comprised of at least Catalase, Reduced Glutathione, Acetylated Glutathione, DPP-IV protease enzyme, Pepsin, Bromelain, Pancreatin, Vitamin D, and Selenium. The composition can further comprise a palliative agent, and can be provided in specific dosages or administered in forms besides those listed above.

公开(公告)号：US20190000907A1

公开(公告)日：2019-01-03

申请号：US16026541

申请日：2018-07-03

Applicant: Script Essentials, LLC

Inventor： Suzy Cohen

IPC: A61K36/53 ,  A61K31/675 ,  A61K31/198 ,  A61K31/197 ,  A61K31/405 ,  A61K31/4045 ,  A61K36/28 ,  A61K36/185 ,  A61K9/48 ,  A61K9/20 ,  A23L33/105 ,  A23L33/15 ,  A23L33/175

CPC classification number: A61K36/53 ,  A23L33/10 ,  A23L33/105 ,  A23L33/15 ,  A23L33/175 ,  A23V2002/00 ,  A61K9/0053 ,  A61K9/20 ,  A61K9/2068 ,  A61K9/48 ,  A61K9/4875 ,  A61K31/00 ,  A61K31/197 ,  A61K31/198 ,  A61K31/4045 ,  A61K31/405 ,  A61K31/4415 ,  A61K31/675 ,  A61K36/185 ,  A61K36/28 ,  A61K2300/00

Abstract: The present disclosure is a composition, a method of making the composition and method of using such composition preferably in the form of a dietary supplement that, when administered, is capable of treating insomnia and other sleep-related disorders. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least vitamin B6, chamomile extract, passionflower extract, lemon balm extract, L-Theanine, GABA, 5-Hydroxytryptophan, and melatonin, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule, powder, liquid or tablet.

公开(公告)号：US10154681B2

公开(公告)日：2018-12-18

申请号：US15342210

申请日：2016-11-03

Applicant: Script Essentials, LLC

Inventor： Suzy Cohen

IPC: A23L2/52 ,  A61K36/05 ,  A61K36/23 ,  A61K36/73 ,  A61K36/88 ,  A23L33/105 ,  A23L33/135 ,  A61K36/899

Abstract: The present disclosure relates to a compound, method of making the compound, method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of use by any individuals, including patients having thyroid disease or various thyroid-related disorders. The unique combination of the composition is preferably administered orally, and preferably in the form of a drink. In some embodiments, the composition includes at least organic chlorella, organic dulse, organic acai, organic carrot, organic pineapple, apple pectin, organic inulin, PR-4 probiotic strain—preferably “Bacillus Coagulans,” organic wheat grass, organic beet root, organic ulva, organic evaporated cane juice, natural flavorsweet flavor, sodium chloride, citric acid, organic guar gum, creamy vanilla flavor, natural raspberry flavor, and natural mixed berry flavor.

公开(公告)号：US20170266130A1

公开(公告)日：2017-09-21

申请号：US15391462

申请日：2016-12-27

Applicant: Script Essentials, LLC

Inventor： Suzy Cohen

IPC: A61K31/10 ,  A61K9/48 ,  A61K9/20 ,  A23L33/10 ,  A61K38/39 ,  A61K36/324 ,  A61K31/728 ,  A61K36/906 ,  A61K9/00 ,  A61K33/04

CPC classification number: A61K31/10 ,  A23L33/10 ,  A23L33/105 ,  A23L33/17 ,  A23V2002/00 ,  A61K31/728 ,  A61K33/04 ,  A61K36/324 ,  A61K36/906 ,  A61K38/39 ,  A23V2200/316 ,  A23V2200/324 ,  A23V2250/21 ,  A23V2250/5422 ,  A61K2300/00

Abstract: The present disclosure relates to a compound, method of making and method of using such compound preferably in the form of a dietary supplement. The composition, when administered, is capable of treating arthritis and various joint-related pain syndromes. The unique combination of the composition is preferably administered orally. A preferred composition is comprised of at least 10 to 200 mcg of selenium, from about 200 to 1200 mg of MSM, from about 100 to 900 mg of boswellia, from about 1 to 5 mg of type II collagen, from about 25 to 200 mg of hyaluronic acid, and from about 50 to 500 mg of ginger.

公开(公告)号：US20220110918A1

公开(公告)日：2022-04-14

申请号：US17499565

申请日：2021-10-12

Applicant: Script Essentials, LLC

Inventor： Suzy Cohen

IPC: A61K31/4188 ,  A61K36/87 ,  A61K38/44 ,  A61K31/375 ,  A61K33/30 ,  A61K47/44 ,  A61K35/747

Abstract: The present disclosure relates to dietary supplements, for improving dermatological health. In embodiments, the composition is comprised of D-Biotin, grape seed extract, superoxide dismutase, zinc, Vitamin C, Lactobacillus Plantarum, Lactobacillus Reuteri, Lactobacillus Rhamnosus, or combinations/sub-combinations thereof.

公开(公告)号：US20210267911A1

公开(公告)日：2021-09-02

申请号：US17099077

申请日：2020-11-16

Applicant: Script Essentials, LLC

Inventor： Suzy Cohen

IPC: A61K31/07 ,  A61K31/375 ,  A61K31/355 ,  A61K33/30 ,  A61K36/185 ,  A61K36/88 ,  A61K31/05 ,  A61K9/00 ,  A61K47/46

Abstract: The present disclosure relates to compositions for improving vision in a patient and methods of administering a composition to a patient, particularly in the form of a dietary supplement, which addresses vision impairment and promotes the health of a patient experiencing problems associated with deteriorated eyesight, including macular degeneration. The present disclosure also relates to methods for formulating the composition described herein.

公开(公告)号：US10369182B2

公开(公告)日：2019-08-06

申请号：US16026541

申请日：2018-07-03

Applicant: Script Essentials, LLC

Inventor： Suzy Cohen

IPC: A61K36/00 ,  A61K36/53 ,  A61K31/675 ,  A61K31/198 ,  A61K31/197 ,  A61K31/405 ,  A61K31/4045 ,  A61K36/185 ,  A61K9/48 ,  A61K9/20 ,  A23L33/105 ,  A23L33/15 ,  A23L33/175 ,  A61K36/28 ,  A61K9/00 ,  A61K31/00 ,  A61K31/4415 ,  A23L33/10

Abstract: The present disclosure is a composition, a method of making the composition and method of using such composition preferably in the form of a dietary supplement that, when administered, is capable of treating insomnia and other sleep-related disorders. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least vitamin B6, chamomile extract, passionflower extract, lemon balm extract, L-Theanine, GABA, 5-Hydroxytryptophan, and melatonin, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule, powder, liquid or tablet.

公开(公告)号：US20190134165A1

公开(公告)日：2019-05-09

申请号：US16237933

申请日：2019-01-02

Applicant: Script Essentials, LLC

Inventor： Suzy Cohen

IPC: A61K38/48 ,  A61K31/198 ,  A61K9/48 ,  A61K36/704 ,  A61K33/24 ,  A61K33/32 ,  A61K33/30 ,  A61K33/04 ,  A61K33/18 ,  A61K31/714 ,  A61K31/4415 ,  A23L33/16 ,  A23L33/15 ,  A61K33/34 ,  A61K36/87 ,  A23L33/185 ,  A23L33/17 ,  A23L33/105 ,  A23L29/00

Abstract: The present disclosure relates to a compound and method of administering such compound for treating a patient suffering from thyroid disease and various thyroid-related disorders, including hyperthyroid and hypothyroid. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least selenium, zinc, iodine, manganese, molybdenum, ashwaganda root powder, polygonum root extract, a digestive enzyme such as DPP-IV, L-tyrosine and mullein leaf, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule or tablet.

公开(公告)号：US20220023398A1

公开(公告)日：2022-01-27

申请号：US17496734

申请日：2021-10-07

Applicant: Script Essentials, LLC

Inventor： Suzy Cohen

IPC: A61K38/48 ,  A61K31/4415 ,  A61K31/714 ,  A61K33/18 ,  A61K33/04 ,  A61K33/30 ,  A61K33/32 ,  A61K36/704 ,  A61K31/198 ,  A61K36/87 ,  A61K33/34 ,  A23L33/15 ,  A23L33/16 ,  A61K9/48 ,  A23L29/00 ,  A23L33/105 ,  A23L33/17 ,  A23L33/185

Abstract: The present disclosure relates to methods of administering a compound for treating a patient suffering from thyroid disease and various thyroid-related disorders, including hyperthyroid and hypothyroid. The composition is preferably comprised of at least selenium, zinc, iodine, manganese, molybdenum, ashwaganda root powder, polygonum root extract, a digestive enzyme such as DPP-IV, L-tyrosine and mullein leaf, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule or tablet.

公开(公告)号：US20180369306A1

公开(公告)日：2018-12-27

申请号：US15992711

申请日：2018-05-30

Applicant: Script Essentials, LLC

Inventor： Suzy Cohen

IPC: A61K36/07 ,  A61K36/68 ,  A61K36/16 ,  A61K36/23 ,  A61K31/685 ,  A61K31/4748 ,  A61K31/353 ,  A61K31/221 ,  A61K31/714 ,  A61K9/20 ,  A61K9/48 ,  A61P25/28

CPC classification number: A61K36/07 ,  A23L33/00 ,  A23L33/10 ,  A23L33/105 ,  A23L33/15 ,  A23L33/175 ,  A61K9/20 ,  A61K9/48 ,  A61K9/4858 ,  A61K31/221 ,  A61K31/353 ,  A61K31/4748 ,  A61K31/685 ,  A61K31/714 ,  A61K36/16 ,  A61K36/23 ,  A61K36/68 ,  A61P25/28 ,  A61K2300/00

Abstract: The present disclosure is a compound, a method of making the compound and method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of supporting memory, focus, and clarity. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least Hericium Erinaceus, Bacopa Monnieri, ECGC (Epigallocatechin-3-Gallate), Huperzine, Acetyl-L-Carnitine, Vitamin B12, Ginkgo Biloba, Phosphatidylserine, and Gotu Kola, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule, powder, liquid or tablet.